Kidney Disease Evaluation for Patients with Diabetes (KED) | January 2022 | Clinical Corner

January 1, 2022

Kidney Disease EVALUATION for Patients with Diabetes (KED)



The percentage of adults ages 18 to 85 years of age with diabetes, as of December 31 of measurement year, who received a kidney health evaluation.


  1. Factsa
    • Approximately 90% of those with early kidney disease don't know they have it.
    • Approximately 1 in 3 adults with diabetes may have kidney disease or are at risk.
    • Kidney disease affects an estimated 37 million people in the U.S. (15% of the adult population; more than 1 in 7 adults).
    • African Americans are 3 times more likely than Whites, and Hispanics are nearly 1.5 times more likely than non-Hispanics to develop end-stage renal disease (kidney failure).
  2. The Test
    • Kidney Health Evaluation includes both an estimated glomerular filtration rate (eGFR) and a urine albumin-creatinine ratio (uACR).
    • At least one eGFR is required during the measurement period.
    • At least one uACR is required during the measurement period.
      • The uACR is identified by the member having both a quantitative urine albumin test and a urine creatinine test with service dates four or less days apart.
    • the eGFR assesses kidney function while the uACR assesses kidney damage.
    • Results of the KED provide physicians and patients with the critical information they need to identify chronic kidney disease (CKD) and develop a treatment plan which may include additional testing, lifestyle changes, medicine, treating the risk factors for diabetes or a referral to a nephrologist for further evaluation.
    • But once kidneys fail, treatment with dialysis or a kidney transplant is needed.
  3. Exclusions from Testing
    • Evidence of ESRD or dialysis any time during the member’s history.
    • Members receiving palliative care or in hospice during the measurement year.
    • Members 66 years of age and older as of December 31 of the measurement year with frailty and advanced illness (see advanced illness guide).
    • Members 81 years of age or older as of December 31 of the measurement year with frailty.
    • Members that did not have a diagnosis of diabetes and who had a diagnosis of polycystic ovarian syndrome, gestational diabetes or steroid-induced diabetes during the measurement year or the year prior to the measurement year in any setting.